U.S. FDA Approves Prezista (darunavir) for Use in Pregnant Women with HIV

TITUSVILLE, N.J., July 18, 2016 /PRNewswire/ -- Janssen Therapeutics, Division of Janssen Products, LP (Janssen), today announced that the U.S. Food and Drug Administration (FDA) has approved an expansion to the Prezista (darunavir) U.S. Prescribing...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news